SCHEMBL8900722

SCHEMBL8900722

CC(C)Nc1nc(N2CCNCC2)ncc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
AKT3 Q9Y243 1/20 0.40
PTPN11 Q06124 2/20 0.39
CASP1 P29466 2/20 0.39
ACHE P22303 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PRKD1 Q15139 1/20 0.39
PRKD2 Q9BZL6 1/20 0.39
CAMK1D Q8IU85 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28081996 0.75 KDM4E (0.43) ALDH1A1KDM4EPOLBSMN1; SMN2PTPN11
SCHEMBL31148464 0.73 MAPT (0.42) ALDH1A1KDM4EPOLBSMN1; SMN2PTPN11
SCHEMBL3835074 0.73 ATF1 (0.48) ALDH1A1KDM4ECASP1CYP1A2CYP3A4
SCHEMBL6016398 0.72 ALDH1A1 (0.55) ALDH1A1KDM4ESMN1; SMN2CASP1CYP1A2
SCHEMBL28171412 0.71 HCAR3 (0.41) KDM4ESMN1; SMN2HPGDLMNASYK
SCHEMBL9686681 0.71 KDM4E (0.42) ALDH1A1KDM4EPOLBSMN1; SMN2CASP1
SCHEMBL4123893 0.70 TACR1 (0.47) ALDH1A1SMN1; SMN2CASP1CYP1A2CYP3A4
SCHEMBL4112334 0.69 ALDH1A1 (0.54) ALDH1A1CASP1CYP1A2CYP3A4HPGD
SCHEMBL11017308 0.69 CASP1 (0.45) ALDH1A1KDM4ECASP1CYP1A2CYP3A4
Piperazine SCHEMBL6016563 0.69 TACR1 (0.47) ALDH1A1SMN1; SMN2CASP1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799617-A2 Therapeutic agent for neurological diseases MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-10-08 EP disclosed
US-4959368-A PYRIMIDINE DERIVATIVES MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1990-09-25 US disclosed
EP-0257102-A1 AGENTS FOR TREATING NEUROPHATHY Mitsui Chemicals, Inc. (JP) 1988-03-02 EP disclosed